Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis

CompletedOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Arthritis, PsoriaticPsoriasis
Interventions
OTHER

questionnaire

There is no therapeutic intervention in this study. However PASE (Psoriatic Arthritis Screening and Evaluation) and other patient questionnaires will be completed by participants.

Trial Locations (9)

2010

Pfizer Investigational Site, Darlinghurst

2050

Pfizer Investigational Site, Camperdown

2065

Pfizer Investigational Site, St Leonards

2145

Pfizer Investigational Site, Westmead

3053

Pfizer Investigational Site, Parkville

3065

Pfizer Investigational Site, Fitzroy

3128

Pfizer Investigational Site, Box Hill

4152

Pfizer Investigational Site, Carina Heights

5042

Pfizer Investigational Site, Bedford Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00998829 - Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis | Biotech Hunter | Biotech Hunter